@article{93e9da0e7b364f5f8df57d1c67b5364d,
title = "Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: A two-year study",
keywords = "200 mg emtricitabine, Antiviral response, Chronic hepatitis B, Dose response, Emtricitabine, DNA, Viral/blood, Double-Blind Method, Drug Administration Schedule, Follow-Up Studies, Hepacivirus/genetics, Humans, Middle Aged, Alanine Transaminase/blood, Hepatitis B e Antigens/blood, Male, Treatment Outcome, Deoxycytidine/administration \& dosage, Dose-Response Relationship, Drug, Adult, Female, Antiviral Agents/administration \& dosage, Hepatitis B, Chronic/blood",
author = "Gish, \{Robert G.\} and Huy Trinh and Nancy Leung and Chan, \{Francis K.L.\} and Fried, \{Michael W.\} and Wright, \{Teresa L.\} and Chia Wang and Jane Anderson and Elsa Mondou and Andrea Snow and Jeff Sorbel and Franck Rousseau and Lawrence Corey",
year = "2005",
month = jul,
doi = "10.1016/j.jhep.2005.02.017",
language = "English",
volume = "43",
pages = "60--66",
journal = "Journal of Hepatology",
issn = "0168-8278",
number = "1",
}